Trial site
Tokyo Metropolitan Bokutoh Hospital
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis7 trials
- Crohn's disease2 trials
- Immune thrombocytopenia (ITP)2 trials
- Alzheimer disease1 trial
- Hepatitis B1 trial
- Sjögren's disease1 trial
- Stroke1 trial
- Phase
- Phase 39 trials
- Phase 25 trials
- Phase 2/31 trial
- Status
- Active, not recruiting7 trials
- Completed6 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC8 trials
- Abivax S.A.2 trials
- Takeda2 trials
- Bayer1 trial
- Eli Lilly and Company1 trial
- and 2 more
Running trials
Not yet recruiting
Active, not recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Immune thrombocytopenia (ITP)2 recruiting
Closed trials
Completed
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Site data: ClinicalTrials.govUpdated 17 Nov 2026